Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -231,956 | -234,019 | -206,250 | -149,005 | -46,104 |
| Depreciation Amortization | 24,749 | 15,502 | 7,736 | 13,674 | 8,881 |
| Accounts receivable | -52,033 | -35,835 | -24,142 | -12,491 | -13,211 |
| Accounts payable and accrued liabilities | 10,555 | 5,980 | 352 | 3,908 | -951 |
| Other Working Capital | 5 | -2,869 | -8,238 | -7,170 | -10,653 |
| Other Operating Activity | 266,150 | 267,245 | 229,785 | 96,797 | 18,929 |
| Operating Cash Flow | $17,470 | $16,004 | $-757 | $-54,287 | $-43,109 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,837 | -1,037 | -494 | -1,198 | -643 |
| Net Acquisitions | -179,220 | N/A | N/A | -35,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 63 | 0 |
| Investing Cash Flow | $-181,057 | $-1,037 | $-494 | $-36,135 | $-643 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 286,966 | N/A | N/A | 143,598 | N/A |
| Debt Repayment | N/A | N/A | N/A | -64,844 | -7,956 |
| Common Stock Issued | 35,615 | 33,418 | 24,156 | 6,637 | 6,211 |
| Other Financing Activity | 9,385 | 0 | 0 | -18,675 | 0 |
| Financing Cash Flow | $331,966 | $33,418 | $24,156 | $66,716 | $-1,745 |
| Exchange Rate Effect | -78 | -14 | -11 | 99 | 60 |
| Beginning Cash Position | 80,480 | 80,480 | 80,480 | 104,087 | 104,087 |
| End Cash Position | 248,781 | 128,851 | 103,374 | 80,480 | 58,650 |
| Net Cash Flow | $168,301 | $48,371 | $22,894 | $-23,607 | $-45,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,470 | 16,004 | -757 | -54,287 | -43,109 |
| Capital Expenditure | -1,837 | -1,037 | -494 | -1,198 | -643 |
| Free Cash Flow | 15,633 | 14,967 | -1,251 | -55,485 | -43,752 |